Eastern Cooperative Oncology Group: Melanoma trials

The registry lists 11 Melanoma studies with Eastern Cooperative Oncology Group as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 2 6Phase 3 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryCompletedNCT00700882Phase 2Results posted
• Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic MelanomaCompletedNCT00071981Phase 2Results posted
• PEG-Interferon Alfa-2b in Treating Patients With Stage IV MelanomaCompletedNCT00049530Phase 2Results posted
• Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without SargramostimCompletedNCT01489423
• Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With SargramostimCompletedNCT01388569
• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWithdrawnNCT00093678Not applicable
• Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00006385Phase 2
• Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus SyndromeCompletedNCT00003601Phase 2
• Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the GroinCompletedNCT00003444Phase 3
• Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaCompletedNCT00003308Phase 2
• Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic MelanomaCompletedNCT00003027Phase 3